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observations from previous animal studies. Our results sug-
gest a potential regulatory loop between PRODH/POX and 
succinate in regulation of mitochondrial respiration.
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Redox · Energetics · Signaling
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CM-H2DCFDA  5 - ( a n d - 6 ) - C h l o r o m e t h y l - 2 ′ , 7 ′ -
dichlorodihydrofluorescein diacetate, 
acetyl ester
CoQ1  Coenzyme Q1
COX IV  Cytochrome C oxidase subunit IV
DCIP  2,6-Dichlorophenolindophenol
DHP  3,4-Dehydro-l-proline
DMSO  Dimethyl sulfoxide
DOX  Doxycycline
DSP  Dithiobis(succinimidylpropionate)
ETC  Electron transport chain
FCCP  Carbonyl cyanide 
p-trifluoromethoxyphenylhydrazone
NAC  N-acetyl-l-cysteine
NDUFA10  NADH dehydrogenase [ubiquinone] 1 
alpha subcomplex subunit 10
OAB  2-Aminobenzaldehyde
OCR  Oxygen consumption rate
OLIGO  Oligomycin
P5C  Pyrroline-5-carboxylate
PRODH/POX  Proline dehydrogenase/proline oxidase
ROS  Reactive oxygen species
ROT  Rotenone
SDHA  Succinate dehydrogenase subunit A
Abstract Proline dehydrogenase/oxidase (PRODH/
POX) is a mitochondrial protein critical to multiple stress 
pathways. Because of the roles of PRODH/POX in sign-
aling, and its shared localization to the mitochondrial 
inner membrane with the electron transport chain (ETC), 
we investigated whether there was a direct relationship 
between PRODH/POX and regulation of the ETC. We 
found that PRODH/POX binds directly to CoQ1 and that 
CoQ1-dependent PRODH/POX activity required functional 
Complex III and Complex IV. PRODH/POX supported 
respiration in living cells during nutrient stress; however, 
expression of PRODH/POX resulted in an overall decrease 
in respiratory fitness. Effects on respiratory fitness were 
inhibited by DHP and NAC, indicating that these effects 
were mediated by PRODH/POX-dependent reactive oxy-
gen species (ROS) generation. PRODH/POX expression 
resulted in a dose-dependent down-regulation of Com-
plexes I–IV of the ETC, and this effect was also mitigated 
by the addition of DHP and NAC. We found that succinate 
was an uncompetitive inhibitor of PRODH/POX activity, 
inhibited ROS generation by PRODH/POX, and alleviated 
PRODH/POX effects on respiratory fitness. The findings 
demonstrate novel cross-talk between proline and succinate 
respiration in vivo and provide mechanistic insights into 
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SDHB  Succinate dehydrogenase subunit B




Proline dehydrogenase (PRODH), a.k.a. proline oxidase 
(POX), is a mitochondrial inner membrane protein. Oxida-
tion of proline to pyrroline-5-carboxylate (P5C) mediates 
the proline cycle that shuttles NADP(H)/NADP(+) redox 
equivalents between mitochondria and cytosol and forms 
a metabolic interlock with the pentose phosphate pathway 
(Hagedorn and Phang 1983; Phang 1985). Conversion of 
P5C to glutamine or ornithine also connects the proline 
cycle to the TCA and urea cycles, respectively.
PRODH/POX is a mediator of genotoxic, inflammatory, 
and metabolic stress signaling. Originally identified in a 
screen of p53-induced genes (Polyak et al. 1997; Campbell 
et al. 1997), induction of PRODH/POX by p53 was subse-
quently shown to result in mitochondrial-mediated apopto-
sis through generation of reactive oxygen species (ROS) in 
the form of mitochondrial superoxide (Donald et al. 2001; 
Hu et al. 2007; Liu et al. 2005). During hypoxia, tumor 
cells respond with either PRODH/POX-mediated ATP gen-
eration under conditions of low glucose, or pro-survival, 
ROS-mediated autophagy induction when glucose levels 
were normal (Liu et al. 2012). Activation of PRODH/POX 
by PPAR-γ results in PRODH/POX-dependent superox-
ide production that induces beclin-1 gene expression and 
activates protective autophagy versus the toxic effects of 
oxidized low-density lipoproteins (Zabirnyk et al. 2010). 
In adipocytes, PRODH/POX activation of PPAR-α through 
ROS-dependent and FOXO1-mediated induction pre-
vents cell death and inflammation (Lettieri Barbato et al. 
2014). In RKO colorectal cancer cells, induction of nutri-
ent stress by either glucose withdrawal or treatment of 
cells with rapamycin results in increased AMP-activated 
protein kinase (AMPK)-dependent PRODH/POX catalytic 
activity, PRODH/POX-dependent cellular ATP generation, 
and activation of the pentose phosphate pathway (Pand-
hare et al. 2009). In C. elegans, AMPK-mediated upregu-
lation of proline catabolism results in generation of ROS 
that promote an adaptive endogenous stress defense and 
increased lifespan (Zarse et al. 2012). Treatment of embry-
onic stem cells with proline induces their differentiation 
into either a primitive, ectoderm-type cell (Washington 
et al. 2010) or a novel, reversible epiblast stem cell-like 
state (Casalino et al. 2011). Thus, depending on cellular 
and environmental context, PRODH/POX can mediate 
programmed cell death, promote cell survival, or induce 
differentiation.
The mitochondrial respiratory electron transport chain 
(ETC) consists of a series of four protein complexes, known 
as Complexes I–IV, that pass electrons from the electron 
donors NADH and FADH through a series of redox reac-
tions, creating an electrochemical proton gradient that is 
coupled with oxidative phosphorylation and the synthesis 
of ATP by ATP synthase (Chaban et al. 2014). Complex I, 
aka NADH dehydrogenase, passes electrons from NADH 
to reduce ubiquinone to ubiquinol. Complex II, aka succi-
nate dehydrogenase (SDH), couples the oxidation of suc-
cinate to fumarate in the tricarboxylic acid (TCA) cycle 
with the reduction of ubiquinone to ubiquinol in the ETC 
(Hagerhall 1997). Electrons are transferred from this 
ubiquinol pool to Complex III, coenzyme Q-cytochrome 
C reductase, which passes the electrons to the hemeprotein 
cytochrome C. The final step is the transfer of electrons to 
Complex IV, cytochrome C oxidase, which passes the elec-
trons to molecular oxygen to form water and drive the pro-
ton gradient that powers ATP synthase.
The SDH holoenzyme consists of four subunits, known 
as SDHA-D. SDHA contains the succinate binding site and 
flavin-adenine dinucleotide (FAD) redox center; SDHB 
contains three iron-sulfur centers required for electron 
transfer to ubiquinone, and SDHC and SDHD are two 
hydrophilic subunits responsible for anchoring the enzyme 
in the mitochondrial inner membrane. The ubiquinone-
binding site of the holoenzyme is in a pocket formed by 
SDHB, SDHC, and SDHD at the surface of the matrix 
face of the mitochondrial inner membrane (Lancaster 
2002; Horsefield et al. 2004; Sun et al. 2005). Mutations 
in SDHB, SDHC, and SDHD have been found in heredi-
tary paraganglioma (Baysal et al. 2000; Niemann and 
Muller 2000; Astuti et al. 2001), gastrointestinal stromal 
tumors (GISTs) (Pasini et al. 2008), thyroid (Ricketts et al. 
2010; Zantour et al. 2004), and renal tumors (Ricketts et al. 
2008; Vanharanta et al. 2004). There is increasing evidence 
that mutations in SDH can lead to aberrant ROS genera-
tion through errors introduced in electron transport, and 
that this can result in tumorigenesis. ROS can be generated 
at the SDHA subunit during impaired electron transport 
(Yankovskaya et al. 2003). SDHC inactivation mutation in 
C. elegans and 3T3 mouse fibroblasts and electron leakage, 
oxidative stress, apoptosis and increased transformation 
and tumor growth (Adachi et al. 1998; Ishii et al. 2005).
Because of the pleiotropic role of PRODH/POX in cel-
lular energetics and signaling, and its shared localization 
with the ETC on the inner membrane of the mitochondria, 
we sought to determine whether there was a direct relation-
ship between PRODH/POX and regulation of the ETC. 
Using a PRODH/POX-expressing DLD colorectal can-
cer cell model and mouse mitochondria, we demonstrate 
that PRODH/POX passes electrons directly to Coenzyme 
Q1 (CoQ1), and that acute proline treatment in PRODH/
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POX-expressing cells resulted in Complex I- and Com-
plex II-independent oxidative respiration during nutrient 
stress conditions. In contrast, exposure of cells to PRODH/
POX and proline resulted in a significant time and depend-
ent decrease in total oxidative respiration due to PRODH/
POX-dependent ROS production. PRODH/POX had dose-
dependent effect on the protein levels of individual subu-
nits of Complexes I–IV of the ETC, which was reversed 
with the PRODH/POX inhibitor DHP and the antioxidant 
l-NAC. We show here that succinate inhibits PRODH/
POX through uncompetitive inhibition, and treatment of 
cells with succinate inhibits production of PRODH/POX-
dependent ROS, mitigates inhibition of respiration by 
PRODH/POX, and restores protein levels of ETC com-
plexes in PRODH/POX-treated cells. These results suggest 
that PRODH/POX acts as a regulator of cellular respira-
tion and that PRODH/POX activity is functionally linked 




Rotenone, 2-thenoyltrifluoroacetone, antimycin A, myxo-
thiazol, potassium cyanide, 3,4-dehydro-l-proline, car-
boxin, methyl-succinate, l-proline, coenzyme Q1, doxy-
cycline, N-acetyl cysteine, and o-aminobenzaldehyde were 
purchased from Sigma Aldrich, St. Louis, MO. Atpenin 
A5 was purchased from Santa Cruz Biotechnology, Dallas, 
Texas.
Cell culture and reagents
DLD-1 Tet-Off POX cell (DLD-POX) generation has been 
previously described and were cultured with modification 
(Liu et al. 2005). The cells were maintained in DMEM 
containing 5 mM glucose (Life Technologies, Inc., Grand 
Island, NY) supplemented with 10 % fetal bovine serum 
(HyClone Laboratories, Logan, UT), 2 mM Glutamax, 
0.4 mg/ml G418, and 0.25 mg/ml hygromycin B (Life 
Technologies), and 20 ng/ml DOX (Sigma).
Mouse liver mitochondria isolation
Mouse liver mitochondria were prepared in the method 
of Chappell and Hansford (Birnie 1972). In brief, freshly 
harvested livers were minced and washed 3× in ice-cold 
sucrose buffer (0.25 M sucrose, 3.4 mM tris–HCl, 1 mM 
EDTA, pH 7.4). Liver tissue was homogenized by 5 passes 
in a Dounce homogenizer. Homogenates were then cen-
trifuged once at 478×g for 10 min, and the supernatant 
centrifuged at 10,000×g for 7 min. The pellet was washed 
with 25 ml ice-cold sucrose buffer and centrifuged 4 times 
at 10,000×g for 7 min, then resuspended in 3 ml ice-cold 
sucrose buffer. Protein concentration was determined using 
a BCA kit following the manufacturer’s instructions (Life 
Technologies).
Measurement of PRODH/POX catalytic activity
PRODH/POX activity was measured as previously 
described, with minor modification (Pandhare et al. 2009). 
After treatment, cells were washed with cold PBS and har-
vested by trypsinization. Cells were resuspended in cold 
sucrose buffer [0.25 M sucrose, 3.5 mM Tris, and 1 mM 
EDTA (pH 7.4)] containing 1× protease inhibitor cocktail 
1 and 2 (Sigma) and then sonicated for 20 s at a setting of 
20 % (Branson Sonifier 450; Branson Ultrasonics Corp., 
Danbury, CT). Total protein was determined using the BCA 
protein assay (Pierce). A 1 ml reaction mixture containing 
0.1 M KPO4, pH 7.2, 0.12 mg/ml o-aminobenzaldehyde 
(OAB), 0.012 mg/ml cytochrome C, 5 mM proline, and 
cell extract containing 50–100 μg protein was incubated 
for 20–60 min at 37 °C. The reaction was terminated by 
addition of 20 μl of OAB (10 mg/ml in 6 N HCl). The sam-
ples were centrifuged and the absorbance of the OAB–P5C 
complex was measured at 440 nm. A standard calibration 
curve was generated using purified P5C.
Oxygen consumption rate assays
XF24 cell culture plates were seeded with 5 × 105 cells 
and allowed to attach overnight. For PRODH/POX expres-
sion, cells were washed 3× with PBS and plated in DMEM 
containing the indicated amount of DOX and media treat-
ment. One hour prior to the assay, cells were washed 2× 
with PBS and plated in Seahorse assay media containing 
5 mM glucose and 2 mM glutamine, and adjusted to pH 
7.4. Cells were incubated for 1 h at 37 °C in a no CO2 incu-
bator. Assay reagents (DMSO, oligomycin, FCCP, rote-
none, and antimycin A) were loaded at a final concentration 
of 2.5 µM. Seahorse calibration, mitochondrial fitness tests, 
and oxygen consumption measurements were performed as 
per manufacturer’s instructions (Seahorse Biotechnology, 
Massachusetts).
Measurement of reactive oxygen species
Cells were washed 3× with Dulbecco’s PBS (DPBS), 
then placed in DPBS containing 5 µM of 5-(and-6)-
chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, 
acetyl ester (CM-H2DCFDA; Life Technologies). Cells 
were exposed to the dye for 20 min in a 37 °C incubator. 
The fluorescence intensity was determined on an adherent 
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cell laser cytometer (ACAS; Meridian Instruments, Inc. 
Okemos, MI) using 488 nm excitation and 560 nm fluo-
rescence detection. Quantitation was based on total protein 
measured per well using the BCA protein quantitation kit 
as per manufacturer’s protocol (Life Technologies).
Measurement of electron transfer
Catalytic activity of SDH and PRODH/POX was measured 
using 2,6-dichlorophenolindophenol (DCIP) in the method 
of Hatefi and Stiggall with modification (Hatefi and Stiggall 
1978). 50–100 µg of mouse mitochondria was suspended in 
1 ml assay buffer containing 2 mM KCN, 20 mM KPO4, 
50 µM DCIP, 100 µM CoQ1, and either 10 mM methyl-
succinate or proline. Reactions were incubated at 37 °C for 
10 min. Changes in absorbance at 600 nm were calculated 
versus negative control and blank.
Crosslinking and co‑immunoprecipitation
Mitochondrial proteins were cross-linked using dithiobi
s(succinimidylpropionate) (DSP) according to manufac-
turer’s instructions (Thermo Fisher Scientific; Waltham, 
MA). Briefly, 200 mg of mouse mitochondrial fractions 
was washed 3× in ice-cold PBS. Mitochondria were sus-
pended in cold PBS containing 2.5 mM of DSP and incu-
bated on ice for 2 h. Reaction was quenched by addition 
of 50 mM Tris–HCl. Immunoprecipitation of Complex II 
was performed using the monoclonal Complex II immu-
nocapture antibody (Abcam, Cambridge, MA) following 
manufacturer’s protocol. Mitochondria were solubilized 
by the addition of 1 % lauryl maltoside (LM) and 1× pro-
tease inhibitor cocktail 1 and 2 (Sigma Aldrich) and incu-
bated on ice for 30 min. Mitochondria were centrifuged at 
14,000×g at 4 °C for 10 min to pellet insoluble material. 
Lysates were incubated with either 10 µg of Complex II 
antibody, PRODH monoclonal antibody (A-11; Santa Cruz 
Biotechnology), or mouse IgG control (Abcam) on ice for 
1.5 h. 50 µl of a 50 % slurry of TrueBlot Anti-Mouse IP 
Beads (Rockland Antibodies, Limerick, PA) was added and 
samples placed on a rotator overnight at 4 °C. Beads were 
washed 3× with cold PBS containing 0.1 % LM and sus-
pended in 100 µl of Laemelli SDS-page buffer.
Western blotting
Cell lysates were prepared and quantified according to 
established methods. To each well of a 4–12 % or 12 % 
SDS-polyacrylamide gel, 15–30 μg total protein was 
applied, electrophoresed, and transferred to nitrocellu-
lose membrane using an iBlot semi-dry transfer appara-
tus (Life Technologies). Membranes were blocked using 
Tris-buffered saline with 5 % nonfat milk (pH 7.6; Sigma). 
Primary antibodies used in this study were SDHA, SDHB, 
Histone H3 (Abcam), PRODH/POX, NDUFA10, Complex 
III Rieske FeS (Santa Cruz), Dimethyl Histone H3 (K4), 
Dimethyl Histone H3 (K36), COX IV (Cell Signaling, 
Danvers MA), β-actin (Novus Biologicals, Littleton, CO), 
and subsequently by a secondary anti-mouse/anti-rabbit 
IgG antibody conjugated to horseradish peroxidase (Jack-
son ImmunoResearch, West Grove, PA). All blots were 
washed in Tris-buffered saline with Tween 20 (pH 7.6; 
Sigma). Detection was done using an ECL kit (GE Health-
care, Pittsburgh, PA). Signals were quantified using Image 
Studio Light V5 (LI-COR Biosciences, Lincoln, NE).
Statistical methods
For analysis of mechanisms of inhibition of POX by SDH 
inhibitors and succinate, data in this study were evaluated 
using linear and nonlinear regression analysis, Lineweaver–
Burk double-reciprocal plot analysis, and analysis of 
covariance (ANCOVA). Precise estimates of Vmax and Km 
were estimated using modern nonlinear regression (Bates 
and Watts 1988) methods. Intercepts (1/v0) and slopes 
(Km/Vmax), which were back-calculated from the Vmax and 
Km estimates obtained from nonlinear regression analy-
ses, were found to be virtually identical to intercept and 
slope estimates obtained from linear regression analyses 
using the double-reciprocal Lineweaver–Burk strategy. 
ANCOVA was used to determine statistical equivalence of 
intercept and slope estimates in connection with inferences 
regarding competitive or uncompetitive inhibition in the 
CoQ1, SUCC, and TTFA analyses (N AWaC2014; Alvord 
2014; Venables et al. 2002). Statistical analyses were per-
formed with the R Statistical Language and Environment 
(Team RC 2014).
Results
Coenzyme Q1 is electron acceptor for PRODH/POX
It was recently shown that recombinant PRODH/POX iso-
lated from S. Cerevisae bound directly to CoQ1 and that 
this was the mechanism by which PRODH/POX fed elec-
trons from proline into the electron transport chain (Wan-
duragala et al. 2010). In addition, we have previously dem-
onstrated that PRODH/POX catalysis of proline can be 
used to support ATP generation under conditions of acute 
nutrient stress (Pandhare et al. 2009).
To assess PRODH/POX utilization of CoQ1 as an elec-
tron acceptor in our DLD-POX cell model, we added 
increasing amounts of CoQ1 to DLD-POX lysates and 
monitored PRODH/POX catalytic activity. As shown in 
Fig. 1a, PRODH/POX activity increased with increasing 
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Fig. 1  PRODH/POX supports respiration independent of Complex 
I and II activity. a POX activity assay showing the increase in POX 
activity in the presence of increasing CoQ1. DLD-POX cells were 
grown in 0.2 ng/ml DOX to allow POX expression. Homogenized 
cell lysate containing 100 μg protein was incubated in assay buffer 
with 0, 25, 50, 100, 250, and 500 μM of CoQ1 at 37 °C for 20 min. 
Absorbance at 440 nm was measured to assess the amount of OAB–
P5C complex formed. A P5C standard curve was used to calculate 
the P5C concentration. Data shown represent mean ± SEM. Com-
pared to CoQ1 = 0, all values are significant to p < 0.001. b Dou-
ble-reciprocal analysis of CoQ1-dependent POX activity. DLD-POX 
lysate with 100 µg protein was incubated with 1, 2, 5, or 10 mM of 
proline and 25, 50, 75, or 100 µM of CoQ1 in assay buffer at 37 °C 
for 20 min. Absorbance at 440 nm was used to measure the amount 
of OAB–P5Ccomplex formed and a P5C standard curve used to 
calculate the P5C concentration. c PRODH/POX activity in DLD-
POX lysates and mouse mitochondria show similar dependence on 
ETC function. PRODH/POX-containing lysates (200 µg protein) or 
mouse mitochondria (50 µg protein) were incubated in assay buffer 
at 37 °C for 30 min. Sensitivity of PRODH/POX activity to ETC 
function was measured by the addition of 50 µM ROT, 2 mM TTFA, 
5 µM of AA5, 100 µM of AMA, and 1 mM KCN. Data shown rep-
resent mean ± SEM. *p < 0.01 compared to its respective control. 
d PRODH/POX expression is required for proline to support respira-
tion during acute nutrient stress. DLD-VEC control cells (VEC) and 
DLD-POX cells (POX) were grown in 0.2 ng/ml DOX for 48 h. Cells 
were incubated in glucose-free media alone (CON) or with the addi-
tion of 5 mM proline (+PRO) for 1 h prior to Seahorse XF24 analy-
sis. OCR was measured and a respiratory profile was established by 
the addition of 2.5 µM DMSO, OLIGO, FCCP, and ROT/AMA at the 
indicated time points. *p < 0.01 compared to vector control. e Sea-
horse XF24 oxygen consumption analysis of DLD-POX control cells. 
Cells were grown in 20 ng/ml DOX to suppress PRODH/POX expres-
sion. 1 h prior to analysis, cells were incubated in assay media con-
taining 5 mM glucose and either 0 (CON), 1, or 5 mM proline (PRO). 
OCR was measured at the indicated timepoints. ROT and AA5 were 
added at 2.5 uM to inhibit Complex I and Complex II activity, respec-
tively. AMA was added at 2.5 μM to inhibit Complex III. Compared 
to control, *p < 0.01; +p < 0.02. f Experimental details as described 
for (e), except in this case, DLD-POX cells were grown in 0.2 ng/
ml DOX for 48 h prior to assay. Compared to control, +p < 0.001; 
*p < 0.01. The following abbreviations apply: AA5 atpenin A5, AMA 
antimycin A, CoQ1 coenzyme Q1, DMSO dimethyl sulfoxide, DOX 
doxycycline, FCCP carbonyl cyanide p-trifluoromethoxyphenylhy-
drazone, KCN potassium cyanide, OAB 2-aminobenzaldehyde, OCR 
oxygen consumption rate, OLIGO oligomycin, PRODH/POX proline 
oxidase, ROT rotenone, TTFA 2-thenoyltrifluoroacetone
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CoQ1 in a dose-dependent and saturable manner. These 
data indicate that PRODH/POX utilizes CoQ1 as an elec-
tron acceptor in the oxidation of proline to P5C.
To further characterize its interaction with CoQ1, we 
performed PRODH/POX activity assays using increas-
ing concentrations of proline and CoQ1 to generate a 
Lineweaver–Burk plot (Fig. 1b). Under our experimental 
conditions, the Vmax and Km values were 9.72 ± 0.35 µM 
P5C min−1 and 0.42 ± 0.098 mM proline, respectively, 
using 25 µM of CoQ1. The Vmax and Km increased to 
21.97 ± 0.47 µM P5C min−1 and 1.2 ± 0.09 mM proline, 
respectively, using 100 µM CoQ1. In a global analysis of 
covariance of the four data sets, there was no significant 
difference in the slopes at the α = 0.01 level of confidence, 
p = 0.011. This indicates that PRODH/POX binds directly 
to CoQ1 without the formation of a tertiary complex, con-
sistent with recent reports (Wanduragala et al. 2010).
To determine whether PRODH/POX activity was 
dependent on ETC function, we compared PRODH/POX 
activity in DLD-POX cell lysates and mouse mitochondria 
in the presence of ETC inhibitors. We examined PRODH/
POX activity in the presence of CoQ1 alone or in combi-
nation with rotenone (ROT), an inhibitor of Complex I, 
2-thenoyltrifluoroacetone (TTFA) or atpenin A5 (AA5), 
inhibitors of Complex II, antimycin A (AMA), an inhibitor 
of Complex III, or potassium cyanide (KCN), an inhibitor 
of Complex IV. In both isolated mitochondria and DLD-
POX cell lysates, addition of ROT only modestly affected 
PRODH/POX activity, whereas addition of TTFA signifi-
cantly reduced PRODH/POX activity (Fig. 1c). This was 
not the case with AA5, which had no effect on PRODH/
POX activity. When AMA or KCN was added to the reac-
tion, PRODH/POX catalytic activity was dramatically 
reduced. Thus, in both DLD-POX cells and mouse mito-
chondria, the transfer of electrons from proline to CoQ1 
by PRODH/POX was dependent on downstream electron 
transfer from CoQ1 to Complexes III and IV.
Acute expression of PRODH/POX during nutrient stress 
led to PRODH/POX- and proline-dependent ATP genera-
tion and cell survival (Pandhare et al. 2009). To determine 
whether PRODH/POX supported oxidative respiration dur-
ing acute nutrient stress, we incubated either DLD-VEC 
cells, containing the vector construct, or DLD-POX cells, 
grown in 0.2 ng/ml doxycycline (DOX) to allow PRODH/
POX expression, for 48 h in proline-free media. We then 
placed the cells in glucose-free media with or without the 
addition of 5 mM proline for 1 h, and measured cellular oxy-
gen consumption rate (OCR). Whereas the DLD-VEC cells 
did not respond to proline treatment, the DLD-POX cells 
were able to support a stable respiratory profile (Fig. 1d).
For additional evidence that PRODH/POX could support 
respiration solely through proline oxidation, we incubated 
induced and uninduced DLD-POX cells in proline-free 
media for 48 h, and then in media containing 0, 1, and 
5 mM proline for 1 h, and measured cellular OCR. After 
measurement of basal respiration, ROT and AA5 were 
added to eliminate the contributions of Complex I and 
Complex II to respiration. As shown in Fig. 1e, f, addi-
tion of ROT and AA5 reduced respiration to approximately 
30 % of normal basal respiration in cells in which PRODH/
POX expression was uninduced. The addition of 5 mM 
proline to uninduced control cells resulted in only a slight 
recovery of respiration (Fig. 1e). In contrast, addition of 
proline to PRODH/POX-expressing cells restored respira-
tion at both 1 mM (approximately 50 % basal) and 5 mM 
(approximately 80 % basal; Fig. 1f). Addition of AMA 
inhibited respiration in all conditions shown in Fig. 1e, 
f, indicating that the observed oxygen consumption was 
dependent on Complex III. This data indicates that proline 
is a PRODH/POX-dependent respiratory substrate during 
acute nutrient stress and that it acts independently of Com-
plex I and Complex II but requires functional Complex III.
Effect of PRODH/POX on respiratory fitness
Our data indicated that PRODH/POX and proline can sup-
port respiration during acute nutrient stress. We investigated 
the effects of PRODH/POX expression on overall respira-
tory fitness and capacity. We grew DLD-VEC control cells 
and DLD-POX cells for 3 days with 20, 0.2, 0.02 and 0 ng/
ml of DOX to allow for increasing levels of PRODH/POX 
expression. Manipulation of DOX concentration in DLD-
VEC cells had no effect on respiration (Fig. 2a), but DLD-
POX cells showed a decrease in both basal and maximal 
respiratory capacity that was directly proportional to DOX 
concentration (Fig. 2b).
We examined the effects on respiration resulting from 
increasing duration of PRODH/POX expression alone or 
with the addition of proline to the media. DLD-POX cells 
were grown in either 20 ng/ml DOX as a negative control 
or 0.2 ng/ml of DOX to allow PRODH/POX expression for 
3 or 5 days in the presence or absence of 5 mM added pro-
line. In control cells, proline alone had no effect on basal 
or maximal respiration, even after 5 days (Fig. 2c). In con-
trast, expression of PRODH/POX significantly decreased 
basal and maximal respiration at both 3 and 5 days, and 
proline addition exacerbated this effect (Fig. 2c). Thus, 
PRODH/POX-dependent inhibition of respiration can be 
modulated by the duration of PRODH/POX expression and 
the availability of proline.
PRODH/POX is a well-established superoxide gen-
erator, and the majority of effects of PRODH/POX on 
signaling are due to generation of ROS (Liu et al. 2006; 
D’Aniello et al. 2015; Pang and Curran 2014). We inves-
tigated whether effects of PRODH/POX on respiration 
were due to ROS production. DLD-POX cells were grown 
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Fig. 2  Extended PRODH/POX ROS production decreases total respira-
tory fitness. Data for each time point represents mean ± SEM (n = 3) for 
all panels. a DOX concentration does not affect respiration in DLD-VEC 
control cells. Cells grown for 48 h in the indicated concentration of DOX. 
Oxygen consumption rate (OCR) was measured and a cellular respira-
tory profile was established by the addition of 2.5 µM DMSO, OLIGO, 
FCCP, and ROT/AMA at the indicated timepoints. b Increasing PRODH/
POX expression correlates with lower cellular respiration. DLD-POX 
cells were grown in the indicated amount of DOX and oxygen consump-
tion rate was analyzed as in (a). Values with DOX = 0.02 and 0.0 were 
compared to DOX = 20; *p ≤ 0.01; +p < 0.02. c Prolonged PRODH/
POX expression and addition of proline correlates with greater decreases 
in respiration. DLD-POX cells were grown in 0.2 ng/ml DOX to allow 
PRODH/POX expression for 3 days (3D POX) or 5 days (5D POX) alone 
or in media supplemented with 5 mM proline (3D POX + PRO and 5D 
POX + PRO). Respiration by these cells was compared to DLD-POX cells 
that had been grown for 5 days in 20 ng/ml DOX to suppress PRODH/
POX expression, alone or in combination with 5 mM proline (5D CON 
and 5D CON + PRO, respectively). Oxygen consumption rate was meas-
ured and a respiratory profile established as described in (a). Values for 
3D POX + PRO, 5D POX, and 5D POX + PRO were compared to 5D 
CON. +p ≤ 0.05; *p < 0.01. d Inhibition of PRODH/POX-mediated ROS 
decreases effects on respiration. DLD-POX cells were grown for 48 h in 
either 20 ng/ml DOX (CON), or 0.2 ng/ml DOX alone (POX) or in combi-
nation with 5 or 10 mM  of N-acetyl-l-cysteine (NAC). Oxygen consump-
tion rate was measured and a respiratory profile established as described 
in (a). Compared to control, *p < 0.001; Compared to POX, +p < 0.01. 
e PRODH/POX expression down-regulated ETC component proteins. 
DLD-POX cells were grown in the indicated ng/ml concentration of dox-
ycycline (DOX) for 48 h, alone or in combination with 10 mM DHP or 
NAC. Whole cell lysates were harvested, and protein expression of subu-
nits of Complex I (NDUFA10), Complex II (SDHA and SDHB), Complex 
III (CIII-R, Reiske Fe-S subunit), and Complex IV (COX IV) were ana-
lyzed by Western blotting. β-Actin was used as a protein loading control. 
The band intensities shown below each panel were quantified using Image 
Studio, normalized to β-actin control, and expressed as the level relative to 
untreated control (lane 1 20 ng/ml DOX). Values for DHP and NAC were 
compared to the mean ± STD of the ratios for 0.2 ng/mL DOX (lane 3 
e and lane 2, Fig. 5a) combined with those for 0.02 ng/ml DOX (lane 4 
e) Although the DOX concentration for DHP and NAC treatment was 
0.02 ng/mL DOX, the values at 0.02 ng/ml DOX were consistently lower 
than those at 0.2 ng/ml DOX. Thus, the values used represent a higher dis-
tribution for the PRODH/POX-mediated effect on ETC proteins. DHP and 
NAC increased the values of the ETC proteins, i.e., decreased the effect 
of PRODH/POX. *Value greater than 2 standard deviations of aforemen-
tioned distribution, denoting 95 % confidence limits
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in 0.2 ng/ml DOX for 3 days with 5 mM proline alone 
or with the addition of 5 or 10 mM of the antioxidant 
N-acetyl-l-cysteine (NAC). Expression of PRODH/POX 
with proline showed a dramatic suppression of oxidative 
respiration, and NAC mitigated their inhibitory effects on 
and preserved both basal and maximal respiratory capacity 
(Fig. 2d). These results demonstrate that basal and maximal 
respiratory capacity are modulated by levels of PRODH/
POX induction and proline availability, and that this effect 
is mediated by ROS generation.
As shown in Fig. 2, PRODH/POX down-regulates cel-
lular respiration through ROS production. We examined the 
effects of PRODH/POX-dependent ROS on ETC compo-
nent proteins. To correlate changes in proteins to functional 
effects on respiration, we grew DLD-POX cells in 20, 2, 
0.2, and 0.02 ng/ml of DOX and monitored ETC proteins 
at increasing levels of PRODH/POX expression (Fig. 2e, 
lanes 1–4, respectively). In addition, cells were incubated 
in 0.02 ng/ml of DOX together with either the PRODH/
POX inhibitor dehydroproline (DHP) (Fig. 2e, lane 5) or 
NAC (Fig. 2e, lane 6). To assess statistical significance of 
DHP and NAC, we calculated mean ± standard deviation 
of the values for 0.2 and 0.02 ng/ml DOX from Figs. 2e and 
5a. Increasing PRODH/POX expression decreased levels of 
the NDUFA10 subunit of Complex I, SDHA and SDHB, 
the Reiske subunit of cytochrome C reductase (Complex 
III), and subunit IV of cytochrome C oxidase (COX IV, 
Complex IV). Importantly, SDHA, SDHB and CIII-R were 
restored by either NAC or DHP or by both (Fig. 2e, lanes 
5 and 6, respectively. See legend to Fig. 2e). Compared to 
the POX levels, the values for DHP and NAC indicated by 
an asterisk were outside of 2 standard deviations from the 
mean of the POX controls. Taken together, these results 
provide preliminary evidence that PRODH/POX modulates 
respiration through ROS-mediated down-regulation of ETC 
component proteins.
PRODH/POX is inhibited by Complex II inhibitors 
and succinate
We showed in Fig. 1c that TTFA inhibited PRODH/POX 
activity whereas AA5 did not. The crystal structure of SDH 
with bound TTFA or AA5 has been solved; both are com-
petitive inhibitors of the ubiquitin-binding site, with AA5 
binding at a site more deeply embedded in the enzyme’s 
catalytic site (Sun et al. 2005; Miyadera et al. 2003; Horse-
field et al. 2006). To compare the inhibitory potency of 
TTFA and AA5 for PRODH/POX versus SDH, we per-
formed enzyme activity assays with either proline or suc-
cinate as the substrate. Carboxin, an additional competitive 
inhibitor of the ubiquitin-binding site of SDH (Ruprecht 
et al. 2009), was also tested. Both TTFA and carboxin 
inhibited SDH and PRODH/POX activity with similar 
efficacy, with TTFA inhibiting 60 % and 35 % and car-
boxin inhibiting 36 and 42 % of SDH and PRODH/POX 
activity, respectively. In contrast, AA5 was selective toward 
SDH, inhibiting its activity by 83 % whereas it only inhib-
ited PRODH/POX activity by 9 % versus control (Fig. 3a).
To elucidate the mechanism by which TTFA inhibited 
PRODH/POX activity, we performed POX activity assays 
to construct a Lineweaver–Burk plot (Fig. 3b). Vmax was 
only modestly decreased, being 17.2 ± 0.4 µM P5C min−1 
for control and 16.4 ± 0.3 µM P5C min−1 with the addi-
tion of 2 mM TTFA. In contrast, 2 mM TTFA increased Km 
from 0.65 ± 0.05 mM proline to 2.7 ± 0.35 mM proline. 
Statistical tests were performed for the equivalence of the 
y-intercepts for TTFA data pairs. All p values were greater 
than 0.05, indicating that the y-intercepts for TTFA data 
were statistically equivalent. Together, these results suggest 
that TTFA acts as a competitive inhibitor of PRODH/POX.
We compared the mechanism by which succinate inhib-
its PRODH/POX activity. We again performed PRODH/
POX activity assays to construct a Lineweaver–Burk plot 
(Fig. 3c). Addition of 5 mM succinate decreased both 
Vmax and Km from 19.1 ± 0.4 to 8.8 ± 0.3 µM P5C min−1 
and 1.1 ± 0.08 mM proline and 0.55 ± 0.09 mM proline, 
respectively, versus control. In a global analysis of covari-
ance of the four experimental data sets, there was no signif-
icant difference in the slopes at the α = 0.05 level of confi-
dence, p = 0.75. This indicates succinate inhibits PRODH/
POX activity through uncompetitive inhibition.
To examine whether PRODH/POX and SDH could be 
physically associated on the mitochondrial inner mem-
brane, we performed cross-linking and co-immunoprecip-
itation assays. We incubated mouse mitochondria with the 
protein cross-linker DSP, dissolved the mitochondria with 
1 % laurel maltoside and immunoprecipitated using an anti-
body versus either PRODH/POX or Complex II. We then 
immunoblotted for PRODH/POX and the A and B subunits 
of SDH. Immunoprecipitation of PRODH/POX resulted 
in co-immunoprecipitation of both SDHA and SDHB. In 
addition, PRODH/POX co-immunoprecipitated with Com-
plex II when an anti-Complex II was used (Fig. 3d). These 
data indicate that PRODH/POX and Complex II co-local-
ize on the surface of the mitochondrial matrix membrane 
within the length of the DSP spacer arm (12 angstroms).
Succinate inhibits PRODH/POX‑dependent ROS 
generation
Our data suggested that PRODH/POX and proline control 
mitochondrial respiration through ROS-mediated down-
regulation of ETC proteins. In addition, our data showed 
that succinate inhibits catalytic activity of PRODH/POX. 
We were intrigued whether succinate would modulate 
the PRODH/POX effect on the ETC. DLD-POX cells 
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were grown in 0.2 ng/ml of DOX to allow PRODH/POX 
expression, alone or in combination with 5, 10, or 20 mM 
of methyl-succinate. Cells were then treated with general 
ROS indicator 5-(and-6)-chloromethyl-2′, 7′-dichlorodihy-
drofluorescein diacetate, acetyl ester (CM-H2DCFDA) to 
detect total cellular ROS. PRODH/POX expression resulted 
in a threefold increase in detectable ROS generation versus 
uninduced control; this ROS generation was inhibited by 
succinate in a dose-dependent manner (Fig. 4a).
To determine whether succinate inhibition of PRODH/
POX protected against the PRODH/POX-dependent down-
regulation of respiration, we grew DLD-VEC and DLD-
POX cells in media containing proline alone or together 
with methyl-succinate. DLD-VEC control cells showed no 
change in basal and maximal respiration whether treated 
with proline, methyl-succinate, or a combination of both 
(Fig. 4b). In contrast, PRODH/POX-expressing cells 
showed a marked reduction of respiration in response to 
proline treatment that was inhibited by co-treatment with 
methyl-succinate (Fig. 4c). Taken together, this data indi-
cates that succinate inhibits the effects of PRODH/POX and 
proline on respiration through the inhibition of PRODH/
POX- and proline-derived ROS.
Succinate inhibition of PRODH/POX restores levels 
of ETC component proteins
Because succinate inhibited PRODH/POX-dependent ROS 
generation, we investigated whether succinate treatment 
could modulate PRODH/POX-mediated down-regulation 
of ETC proteins. DLD-POX cells were grown in either 
20 ng/ml DOX or 0.2 ng/ml DOX to allow PRODH/POX 
expression alone or in combination with increasing con-
centrations of succinate. To link effects on ETC proteins 
with effects on ROS (Fig. 4a), we used increasing concen-
trations of succinate. Expression of PRODH/POX resulted 
in down-regulation of subunits of Complexes I–IV of the 
ETC (Fig. 5, lane 1 vs lane 2). Addition of increasing 
D
POX
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Fig. 3  PRODH/POX activity is regulated by succinate and SDH 
inhibitors and co-localizes with SDH on the mitochondrial inner 
membrane. a PRODH/POX and SDH share similar sensitivity to SDH 
inhibitors except AA5. Mouse mitochondria (440 µg protein) were 
incubated in reaction buffer containing either 10 mM of succinate 
or proline alone (Control) or in the presence of 1 mM TTFA, 1 mM 
Carboxin, or 5 µM AA5 at 37 °C for 10 min. Absorbance was meas-
ured at 600 nm and results calculated as a percent of unreacted con-
trol dye. Data shown represent mean ± SEM (n = 3) of comparisons 
against their respective controls. *p < 0.001; +p < 0.05. b Double-
reciprocal analysis of TTFA-dependent inhibition of PRODH/POX 
activity. DLD-POX lysate containing 100 µg protein was incubated 
with 1, 2, 5, or 10 mM of proline and 0, 0.5, 1 and 2 mM of TTFA in 
assay buffer at 37 °C for 20 min. Absorbance at 440 nm was used to 
measure the amount of OAB–P5C complex formed and a P5C stand-
ard curve used to calculate the P5C concentration. c Double-recipro-
cal analysis of succinate-dependent inhibition of PRODH/POX activ-
ity. DLD-POX lysate containing 100 µg protein was incubated with 
1, 2, 5, or 10 mM of proline and 0, 0.5, 1, and 5 mM of succinate in 
assay buffer at 37 °C for 20 min. Absorbance at 440 nm was used to 
measure the amount of OAB–P5Ccomplex formed and a P5C stand-
ard curve used to calculate the P5C concentration. d Co-immuno-
precipitation of PRODH/POX and Complex II. 4 mg of mouse mito-
chondria was cross-linked with DSP, then solubilized and incubated 
with either PRODH/POX (POX IP) or Complex II antibody (CII IP). 
Control samples were incubated with an equal concentration of a 
non-specific mouse IgG (CON). Samples were incubated with beads 
coated with anti-mouse IgG overnight. Cross-linker was cleaved and 
proteins solubilized with SDS-PAGE buffer. Control and IP lysates 
were immunoblotted versus a 5 % input control (IN) using PRODH/
POX, SDHA, and SDHB antibodies. Data is representative of three 
separate experiments
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concentrations of succinate resulted in restoring protein 
levels for Complexes I–III (Fig. 5, lanes 3–6). Levels of the 
COX IV subunit of Complex IV were not restored by suc-
cinate treatment, but it was the only exception of all of the 
ETC subunits examined.
Since both the decrease in PRODH/POX-generated 
ROS and the mitigation of the PRODH/POX-mediated 
decrease in ETC protein levels appeared to be depend-
ent on the concentration of succinate, we plotted the 
individual ETC proteins versus succinate and showed a 
general concentration dependence (Fig. 5b). This sug-
gested that succinate-dependent inhibition of PRODH/
POX was a common mechanism. With this hypothesis, 
we compared the values for ETC proteins in combi-
nation. Furthermore, we included the values for ETC 
proteins at 0.2 ng/ml DOX from Fig. 2e. These val-
ues represent mean ± STD of ETC proteins. With 
SUC = 0, 0.635 ± 0.091, N = 10, SUC = 10 mM, 
mean = 0.782 ± 0.122, N = 5, different from SUC = 0 
with p = 0.0203; SUC = 20 mM, values were 
0.768 ± 0.156, N = 5, different from SUC = 0, with 
p = 0.0546. These values and statistical differences 
support our working hypothesis of a common mecha-
nism underlying the changes in ETC proteins.
Discussion
In this study, we have examined the interaction of PRODH/
POX with Coenzyme Q1 and with the ETC. While 
PRODH/POX supports respiration in the short term, 
PRODH/POX expression results in a decrease of total cel-
lular respiration through down-regulation of proteins of 
the ETC. Most interestingly, the effects of PRODH/POX 
on respiration and the ETC can be inhibited by succinate, 
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Fig. 4  Succinate inhibits PRODH/POX ROS production and 
effects on respiration. a Succinate inhibits ROS production by 
PRODH/POX-expressing cells. DLD-POX cells were grown for 
48 h in 0.2 ng/ml DOX to allow for PRODH/POX expression alone 
(POX+) or in media supplemented with 5, 10, or 20 mM succinate 
(P + 5S, P + 10S, and P + 20S). Control wells contained DLD-
POX cells grown in 20 ng/ml to suppress PRODH/POX expres-
sion (CON). Cells were treated with DCFDA in DPBS for 20 min 
and fluorescence measured at 488 absorption/530 emission. Sig-
nals were normalized by BCA quantitation of protein levels in each 
well. Comparisons under brackets, *p < 0.01. b Succinate does not 
affect respiration in DLD-VEC control cells. Cells grown for 48 h in 
0.2 ng/ml of DOX in media supplemented with 5 mM proline (PRO), 
10 mM succinate (SUC), or both (PRO/SUC). OCR was measured 
and a respiratory profile was established by the addition of 2.5 µM 
DMSO, OLIGO, FCCP, and ROT/AMA at the indicated timepoints. 
c Succinate inhibits the decrease in respiration induced by PRODH/
POX and proline. DLD-POX cells were grown for 48 h in 0.2 ng/
ml of DOX to allow PRODH/POX expression. Oxygen consumption 
rate (OCR) was measured and a respiratory profile was established 
as described for (b). Comparison of 10 mM succinate to 5 mM PRO, 
+p < 0.01. Comparison of 5 mM POX to 5 MM POX + 10 mM SUC, 
*p < 0.05. Data represents mean ± standard error of the mean (n = 3) 
for all panels
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Our analysis of the relationship between PRODH/POX 
and CoQ1 suggested that POX can transfer proline-derived 
electrons directly to CoQ1 without the formation of a ter-
tiary complex. In addition, selective inhibitors indicated 
that PRODH/POX did not require the activity of Complex I 
or Complex II to support respiration. This is consistent with 
studies in other diverse model systems of PRODH/POX 
activity, including Z. meas (corn) mitochondria, purified 
S. cerevisiae PRODH/POX, and PutA from E. coli (Elthon 
and Stewart 1982; Wanduragala et al. 2010; Moxley et al. 
2011; Abrahamson et al. 1983). In addition, PRODH/POX 
dependence on a functional ETC in our DLD-POX expres-
sion system was almost identical to that of isolated mouse 
mitochondria. Thus, we believe our DLD expression sys-
tem accurately reflects the relationship between PRODH/
POX and the ETC.
PRODH/POX was necessary and sufficient to support 
proline-dependent oxidative respiration during acute nutri-
ent stress, consistent with previous publications showing 
its pro-survival role during nutrient stress (Pandhare et al. 
2009; Liu et al. 2012). In addition, extended expression of 
PRODH/POX (48–96 h) resulted in the down-regulation of 
basal oxidative respiration and maximal respiratory capac-
ity. This effect was dependent on the duration and intensity 
of POX expression as well as the addition of exogenous 
proline, and was inhibited by the co-treatment with NAC. 
Reduction of respiratory capacity correlated with reduction 
in levels of protein subunits of Complexes I–IV of the ETC, 
which was reversed by co-treatment of cells with either 
DHP or NAC. These effects are most readily explained as 
resulting from proline oxidation and ROS generation by 
PRODH/POX.
Inhibition of PRODH/POX by TTFA was through com-
petitive inhibition. Both TTFA and carboxin have previ-
ously been shown to compete for the ubiquinone-binding 
site of SDH that is formed when the 4 SDH subunits com-
bine to form the holoenzyme (Sun et al. 2005; Ruprecht 
et al. 2009). Based on this, one possibility we considered 
was that PRODH/POX required the ubiquitin-binding site 
of SDH for its activity. However, AA5, which has been 
shown to bind deeper in the ubiquinone-binding pocket 
of SDH (Miyadera et al. 2003; Horsefield et al. 2006), 
showed very little inhibition of PRODH/POX. In addition, 
the interaction of PRODH/POX with CoQ1 indicated direct 
binding to PRODH/POX. We think it more likely that the 
SDH inhibitors compete for the ubiquitin-binding site on 
PRODH/POX. The observation that TTFA and carboxin 
can inhibit PRODH/POX and SDH to a similar degree at 
the concentrations used may warrant caution in their use as 
SDH-selective inhibitors.
Although succinate inhibition of PRODH/POX has been 
investigated (Kowaloff et al. 1977; Norden and Matang-
anyidze 1974), to our knowledge this is the first study to 
examine the effects of this inhibition on PRODH/POX-
mediated ROS generation and mitochondrial metabolism. 
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Fig. 5  Succinate inhibits the effects of PRODH/POX on ETC com-
ponent proteins. DLD-POX cells were grown in the indicated ng/
ml concentration of DOX for 48 h, alone or in combination with 
increasing concentrations of succinate as suggested by the effects 
of succinate on ROS (Fig. 4a). a Whole cell lysates were harvested, 
and protein expression of PRODH/POX and of subunits of Complex 
I (NDUFA10), Complex II (SDHA, SDHB), Complex III (CIII-R, 
Reiske Fe-S subunit), and Complex IV (COX IV) was analyzed by 
Western blotting. The band intensities shown below each panel were 
quantified using Image Studio, normalized to β-actin control, and 
expressed as the level relative to untreated control (lane 1 20 ng/ml 
DOX). b Since succinate decreased PRODH/POX-mediated ROS in a 
dose-dependent manner (Fig. 4a) and the levels of proteins in a sug-
gested a succinate concentration effect, we constructed a combination 
plot of protein levels as the fraction of control against succinate con-
centrations (see text). For the value with treatment by POX (0.2 ng/ml 
DOX) without succinate, we combined the values from a with those 
obtained in Fig. 2e. We then compared the values statistically. The 
value with 10 mM succinate was different from that without succi-
nate, *p = 0.020. At 20 mM succinate, the difference was borderline 
significant, +p = 0.055
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uncompetitive inhibition. This mechanism makes it very 
unlikely that the observed effects are due to non-selective 
inhibition of PRODH/POX by succinate. Treatment with 
succinate inhibited PRODH/POX-dependent ROS produc-
tion and prevented PRODH/POX-dependent ROS effects 
on oxidative respiration. Succinate also protected ETC 
component proteins from PRODH/POX ROS-mediated 
down-regulation with almost the same efficacy as DHP and 
NAC.
As an uncompetitive inhibitor, the affinity of succinate 
is for the enzyme-substrate complex of PRODH/POX and 
proline rather than for the enzyme binding site for proline. 
Additionally, our data show that PRODH/POX and SDH 
co-localize on the mitochondrial inner membrane, where 
local substrate concentrations would have the potential to 
affect the activities of both enzymes. Thus, in the presence 
of low levels of proline, higher levels of succinate could 
act to inhibit PRODH/POX activity and ROS generation. 
This may provide an additional level of regulation of 
PRODH/POX stress signaling until cellular levels of TCA 
cycle intermediates fall below a critical point. The specific 
role that SDH plays in the transmission of the PRODH/
POX-generated ROS signal remains to be elucidated, but 
a coordinated role with PRODH/POX would be consistent 
with the observation that SDH-mediated ROS generation 
was essential for a hypoxia-dependent stress response in 
mouse lung sections (Paddenberg et al. 2003, 2012) and 
that Complex II has been found to be a site of ROS gen-
eration resulting from proline oxidation (Goncalves et al. 
2014).
The data presented here introduce a novel relationship 
between PRODH/POX, proline, and succinate and the reg-
ulation of respiration. Depending on cellular context, this 
relationship could provide an additional point of regulation 
between the identified inducers of PRODH/POX and regu-
lation of cellular energy levels and routing of metabolites. 
More intriguing is the possibility that the proline found in 
extracellular collagen may serve both as a source of energy 
for tumors and tissues through proline catabolism, and also 
as a signaling and metabolic link between the extracellu-
lar environment during development and tumor formation. 
It is becoming increasingly apparent that dysregulation of 
metabolism and the resulting change in metabolite levels 
affect not only cell transformation (Ward et al. 2010; Lu 
et al. 2013), but influence tumor cell aggressiveness and 
metastatic potential, as has been shown recently in ovar-
ian cancer and ovarian cancer stem cells (Vermeersch et al. 
2014, 2015). The role of PRODH/POX as a direct media-
tor of ROS-dependent signaling and central mediator of 
metabolic intermediates will, no doubt, continue to play an 
interesting role in cellular development and transformation.
Summary
This work shows for the first time the regulation of respira-
tory fitness by PRODH/POX through downregulation of 
ETC proteins, and the inhibition of these effects by succi-
nate. The existence of a regulatory loop between PRODH/
POX, the ETC, and succinate would link the various stress 
pathways that induce PRODH/POX with ETC regulation 
and TCA cycle metabolite flux. Changes in proline and 
succinate homeostasis may be a mechanism of epigenetic 
gene regulation during differentiation and tumorigenesis, 
and this possibility should be investigated further.
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